Morgan Stanley Raises SJM Price Target to $106, Shifts Focus to Fiscal 2027
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.

Morgan Stanley lifted its J.M. Smucker target to $106 from $104 on June 5 — and the reasoning centers on coffee cost relief and Uncrustables growth in FY2027.
Morgan Stanley raised its price target on The J. M. Smucker Company (NYSE: SJM) to $106 from $104 on June 5, 2026, while reiterating an Equal Weight rating on the shares. The revision follows Smucker's Q4 earnings release filed with the SEC on June 9 and reflects the bank's view that investor attention is shifting toward the company's fiscal 2027 outlook rather than the most recent quarter's results.
What Morgan Stanley Is Watching
- Morgan Stanley raised its price recommendation to $106 from $104, a $2 increase, while maintaining its Equal Weight rating.
- The firm identified fiscal 2027 as the key focus period for investors evaluating Smucker's trajectory.
- Per Smucker's Q4 earnings call, management flagged coffee cost relief as a material driver of the fiscal 2027 plan, alongside Uncrustables volume growth and improved profitability from the Hostess portfolio.
- Smucker guided net sales down 3% to 4% for the coming fiscal year, a concrete headwind the Equal Weight rating appears to reflect.
- TTM operating cash flow stands at $1.29 billion, providing balance sheet flexibility despite the top-line pressure (TTM, may not reflect latest quarter).
Why It Matters
The Q4 earnings call, according to Yahoo Finance, mapped Smucker's fiscal 2027 strategy around three pillars: relief from elevated green coffee costs, continued expansion of the Uncrustables frozen sandwich line, and margin improvement from the Hostess acquisition. The net sales guidance of negative 3% to 4% signals that volume recovery and cost normalization, rather than revenue growth, are the near-term investment thesis.
Jim Cramer, speaking on Mad Money, expressed skepticism about the sustainability of the stock's post-earnings rally, noting that the prior earnings report produced a jump that subsequently reversed. That caution sits alongside a broader analyst consensus that has shifted modestly more constructive: the Buy-equivalent count rose to 14 from 13 between May 1 and June 1, 2026, though the Hold count of 11 reflects lingering uncertainty around the sales trajectory.
Wall Street View
As of June 1, 2026, analyst consensus stands at 5 Strong Buy, 9 Buy, and 11 Hold, with zero Sell or Strong Sell ratings. Morgan Stanley's Equal Weight at $106 sits at the more cautious end of that spectrum. The forward price-to-earnings multiple of 11.0x suggests the market is already pricing in limited near-term growth, which may be why the bank's fiscal 2027 framing carries more weight than the target increment itself.
Investor Takeaway
Morgan Stanley's $2 target increase is a modest revision, but the framing around fiscal 2027 coffee cost normalization and Uncrustables expansion gives investors a specific set of operational milestones to monitor against the company's own guidance of declining net sales. With TTM operating cash flow of $1.29 billion (TTM, may not reflect latest quarter) and a 4% dividend yield noted by Seeking Alpha, Smucker offers income stability while the top-line recovery thesis plays out. The negative sales guidance remains the primary variable that will determine whether the Equal Weight consensus shifts more decisively bullish.
Related Articles
J.M. Smucker Q4 2026 EPS Beats at $2.77, Raises Fiscal 2027 Profit Forecast (SJM)
Walmart (NYSE: WMT) Launches Kacey Musgraves Fashion Line in Cowboycore Push
Amazon Secures $17.5B Loan Facility and Expands Nationwide LTL Freight Service
Morgan Stanley Forecasts AI-Related Global Debt Issuance to Hit $570B in 2026 (NYSE: MS)
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.